Variant report

Variant	nsv9778
Chromosome Location	chr20:1601383-1606274
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:66)
CpG islands
(count:61)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:66 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr20:1603058-1603543	GM12878	blood:	n/a	n/a
2	BATF	chr20:1603174-1603482	GM12878	blood:	n/a	n/a
3	BCL11A	chr20:1603100-1603339	GM12878	blood:	n/a	n/a
4	BCL11A	chr20:1603111-1603444	GM12878	blood:	n/a	n/a
5	BCL3	chr20:1603087-1603515	GM12878	blood:	n/a	n/a
6	BCLAF1	chr20:1603036-1603400	GM12878	blood:	n/a	n/a
7	BHLHE40	chr20:1603122-1603445	GM12878	blood:	n/a	n/a
8	BRCA1	chr20:1603218-1603418	GM12878	blood:	n/a	n/a
9	CHD1	chr20:1601432-1601474	GM12878	blood:	n/a	n/a
10	CHD2	chr20:1603157-1603427	GM12878	blood:	n/a	n/a
11	CUX1	chr20:1603041-1603432	GM12878	blood:	n/a	n/a
12	EBF1	chr20:1603132-1603418	GM12878	blood:	n/a	n/a
13	EBF1	chr20:1603127-1603474	GM12878	blood:	n/a	n/a
14	EBF1	chr20:1603108-1603472	GM12878	blood:	n/a	n/a
15	ELK1	chr20:1603141-1603367	GM12878	blood:	n/a	n/a
16	EP300	chr20:1603064-1603440	GM12878	blood:	n/a	n/a
17	EP300	chr20:1603095-1603461	GM12878	blood:	n/a	n/a
18	FOS	chr20:1605954-1606166	MCF10A-Er-Src	breast:	n/a	chr20:1606092-1606101 chr20:1606093-1606102 chr20:1606139-1606146 chr20:1606139-1606147
19	FOS	chr20:1605238-1605344	MCF10A-Er-Src	breast:	n/a	n/a
20	FOS	chr20:1605171-1605381	MCF10A-Er-Src	breast:	n/a	n/a
21	FOS	chr20:1605947-1606224	MCF10A-Er-Src	breast:	n/a	chr20:1606092-1606101 chr20:1606093-1606102 chr20:1606139-1606146 chr20:1606139-1606147
22	IKZF1	chr20:1603130-1603399	GM12878	blood:	n/a	n/a
23	IRF4	chr20:1603061-1603519	GM12878	blood:	n/a	n/a
24	IRF4	chr20:1603036-1603460	GM12878	blood:	n/a	n/a
25	MAFK	chr20:1602150-1602200	HepG2	liver:	n/a	n/a
26	MAZ	chr20:1603204-1603478	GM12878	blood:	n/a	n/a
27	MTA3	chr20:1603089-1603593	GM12878	blood:	n/a	n/a
28	MTA3	chr20:1603077-1603556	GM12878	blood:	n/a	n/a
29	MXI1	chr20:1603109-1603357	GM12878	blood:	n/a	n/a
30	NFIC	chr20:1602914-1603550	GM12878	blood:	n/a	n/a
31	NFIC	chr20:1604991-1605563	GM12878	blood:	n/a	n/a
32	NFIC	chr20:1605928-1606395	GM12878	blood:	n/a	n/a
33	NFYB	chr20:1603119-1603445	GM12878	blood:	n/a	n/a
34	NRF1	chr20:1603215-1603376	GM12878	blood:	n/a	n/a
35	PAX5	chr20:1604209-1604460	GM12878	blood:	n/a	n/a
36	PAX5	chr20:1603124-1603419	GM12878	blood:	n/a	n/a
37	POLR2A	chr20:1605103-1605213	Hela-S3	cervix:	n/a	n/a
38	POLR2A	chr20:1604998-1605226	Hela-S3	cervix:	n/a	n/a
39	POU2F2	chr20:1603102-1603490	GM12878	blood:	n/a	n/a
40	RCOR1	chr20:1603165-1603429	GM12878	blood:	n/a	n/a
41	RUNX3	chr20:1603131-1603498	GM12878	blood:	n/a	n/a
42	RUNX3	chr20:1603071-1603543	GM12878	blood:	n/a	n/a
43	SMC3	chr20:1603317-1603417	GM12878	blood:	n/a	n/a
44	SMC3	chr20:1604485-1604650	GM12878	blood:	n/a	n/a
45	SPI1	chr20:1600469-1601455	HL-60	blood:	n/a	chr20:1600688-1600701 chr20:1601227-1601234 chr20:1600691-1600698 chr20:1600690-1600699
46	SPI1	chr20:1603028-1603484	HL-60	blood:	n/a	n/a
47	SPI1	chr20:1603181-1603339	GM12878	blood:	n/a	n/a
48	SPI1	chr20:1603095-1603491	GM12878	blood:	n/a	n/a
49	SPI1	chr20:1603109-1603487	GM12891	blood:	n/a	n/a
50	SPI1	chr20:1603125-1603481	GM12891	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:1601704-1601754	LNCaP	prostate:	n/a
2	chr20:1601704-1601754	HCPEpiC	choroid plexus:	n/a
3	chr20:1601704-1601754	NHBE	bronchial:	n/a
4	chr20:1601704-1601754	ProgFib	skin:	n/a
5	chr20:1601704-1601754	HepG2	liver:	n/a
6	chr20:1601704-1601754	GM12892	blood:	n/a
7	chr20:1601704-1601754	HL-60	blood:	n/a
8	chr20:1601704-1601754	GM12891	blood:	n/a
9	chr20:1601704-1601754	NB4	blood:	n/a
10	chr20:1601704-1601754	GM19239	blood:	n/a
11	chr20:1601704-1601754	A549	lung:	n/a
12	chr20:1601704-1601754	HCT-116	colon:	n/a
13	chr20:1601704-1601754	ECC-1	luminal epithelium:	n/a
14	chr20:1601704-1601754	HEK293	kidney:	embryo
15	chr20:1601704-1601754	HRE	kidney:	n/a
16	chr20:1601704-1601754	T-47D	breast:	n/a
17	chr20:1601704-1601754	U87	brain:	n/a
18	chr20:1601704-1601754	CMK	blood:	n/a
19	chr20:1601704-1601754	GM06990	blood:	n/a
20	chr20:1601704-1601754	RPTEC	kidney:	n/a
21	chr20:1601704-1601754	HRCEpiC	kidney:	n/a
22	chr20:1601704-1601754	H1-hESC	embryonic stem cell:	embryo
23	chr20:1601704-1601754	HPAEpiC	pulmonary alveolar:	n/a
24	chr20:1601704-1601754	SK-N-SH_RA	brain:	n/a
25	chr20:1601704-1601754	IMR90	lung:	fetal
26	chr20:1601704-1601754	K562	blood:	n/a
27	chr20:1601704-1601754	HAEpiC	amniotic membrane:	n/a
28	chr20:1601704-1601754	AG10803	skin:	n/a
29	chr20:1601704-1601754	PANC-1	pancreas:	n/a
30	chr20:1601704-1601754	MCF10A-Er-Src	breast:	n/a
31	chr20:1601704-1601754	PFSK-1	brain:	n/a
32	chr20:1601704-1601754	HUVEC	blood vessel:	n/a
33	chr20:1601704-1601754	HMEC	breast:	n/a
34	chr20:1601704-1601754	SK-N-SH	brain:	n/a
35	chr20:1601704-1601754	Caco-2	colon:	n/a
36	chr20:1601704-1601754	AG04450	lung:	fetal
37	chr20:1601704-1601754	AoSMC	blood vessel:	n/a
38	chr20:1601704-1601754	PrEC	prostate:	n/a
39	chr20:1601704-1601754	SAEC	small airway:	n/a
40	chr20:1601704-1601754	HRPEpiC	eye:	n/a
41	chr20:1601704-1601754	GM12878	blood:	n/a
42	chr20:1601704-1601754	SK-N-MC	brain:	n/a
43	chr20:1601704-1601754	BE2_C	brain:	n/a
44	chr20:1601704-1601754	SKMC	muscle:	n/a
45	chr20:1601704-1601754	NHDF-neo	bronchial:	n/a
46	chr20:1601704-1601754	NT2-D1	testis:	n/a
47	chr20:1601704-1601754	BJ	skin:	n/a
48	chr20:1601704-1601754	AG04449	skin:	fetal
49	chr20:1601704-1601754	ovcar-3	ovarian:	n/a
50	chr20:1601704-1601754	AG09319	gingival:	n/a

No data

Variant related genes	Relation type
SIRPB1	TF binding region
ENSG00000260861	TF binding region
SIRPB1	CpG island
ENSG00000260861	CpG island

Extended variants
information (count: 178 )
Associated
traits (count: 66 )

Variant overlapped rSNPs/rCNVs (count:178 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs187217353	chr20:1601413-1601414	Weak transcription Enhancers Flanking Active TSS Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
2	rs544596746	chr20:1601431-1601432	Weak transcription Enhancers Flanking Active TSS Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs570414769	chr20:1601479-1601480	Weak transcription Enhancers Flanking Active TSS Genic enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs528209319	chr20:1601498-1601499	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs546446650	chr20:1601506-1601507	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs567890511	chr20:1601528-1601529	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs114397823	chr20:1601596-1601597	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs147274963	chr20:1601607-1601608	Weak transcription Enhancers Flanking Active TSS Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs561589159	chr20:1601655-1601656	Weak transcription Enhancers Flanking Active TSS Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs148315738	chr20:1601703-1601704	Weak transcription Enhancers Flanking Active TSS Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs539401640	chr20:1601714-1601715	Weak transcription Enhancers Flanking Active TSS Genic enhancers Bivalent Enhancer	CpG island	2 gene(s)	Overlapped CNVs	n/a
12	rs558141417	chr20:1601871-1601872	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs573229289	chr20:1601893-1601894	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs540701198	chr20:1601912-1601913	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs555615415	chr20:1601928-1601929	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs574276595	chr20:1602049-1602050	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs6043330	chr20:1602051-1602052	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs75649571	chr20:1602149-1602150	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs533679242	chr20:1602164-1602165	Weak transcription Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs545449773	chr20:1602204-1602205	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs3761269	chr20:1602206-1602207	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
22	rs528100853	chr20:1602243-1602244	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs6043332	chr20:1602260-1602261	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs546657484	chr20:1602270-1602271	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs141425763	chr20:1602272-1602273	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs150820780	chr20:1602274-1602275	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs528205235	chr20:1602284-1602285	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs370228328	chr20:1602393-1602394	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs192289000	chr20:1602413-1602414	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs539736816	chr20:1602431-1602432	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs551414955	chr20:1602439-1602440	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs566843136	chr20:1602469-1602470	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs533978066	chr20:1602473-1602474	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs576985369	chr20:1602480-1602481	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs555893689	chr20:1602481-1602482	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs574182565	chr20:1602486-1602487	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs76673572	chr20:1602487-1602488	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs538399556	chr20:1602500-1602501	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs139660431	chr20:1602511-1602512	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs551433616	chr20:1602540-1602541	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs578242158	chr20:1602545-1602546	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs73080729	chr20:1602624-1602625	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs560658533	chr20:1602647-1602648	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs572790358	chr20:1602663-1602664	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs386811630	chr20:1602668-1602669	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs76357893	chr20:1602669-1602670	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs528966529	chr20:1602690-1602691	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs550327465	chr20:1602699-1602700	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs2224878	chr20:1602704-1602705	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs79037510	chr20:1602767-1602768	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:66)

Disease	PMID	Source
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Glioblastoma multiforme	22286061	CNVD
Hepatocellular carcinoma	22174799	CNVD
Colorectal cancer	19455253	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17603634	CNVD
Colorectal cancer	19359472	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16774939	CNVD
Autism	18414403	CNVD
Neurocytoma	17123091	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16397240	CNVD
abortions and stillbirths	19751515	CNVD
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	17363583	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Lung cancer	18438408	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:125 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:1596400-1602400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
2	chr20:1598800-1601800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
3	chr20:1599000-1601800	Enhancers	Spleen	Spleen
4	chr20:1599400-1602200	Weak transcription	HUVEC	blood vessel
5	chr20:1599800-1601600	Enhancers	Dnd41	blood
6	chr20:1599800-1601800	Genic enhancers	Primary T cells fromperipheralblood	blood
7	chr20:1599800-1604400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
8	chr20:1599800-1608200	Enhancers	Primary T helper cells fromperipheralblood	blood
9	chr20:1600000-1602000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
10	chr20:1600000-1604400	Enhancers	Primary T helper naive cells from peripheral blood	blood
11	chr20:1600000-1604600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
12	chr20:1600000-1608600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
13	chr20:1600200-1601400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
14	chr20:1600200-1601600	Flanking Active TSS	Primary B cells from cord blood	blood
15	chr20:1600200-1602000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
16	chr20:1600200-1603400	Enhancers	Primary T killer memory cells from peripheral blood	blood
17	chr20:1600200-1605800	Enhancers	Primary B cells from peripheral blood	blood
18	chr20:1600600-1601400	Enhancers	HMEC	breast
19	chr20:1600600-1601600	Enhancers	Duodenum Smooth Muscle	Duodenum
20	chr20:1600600-1601800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
21	chr20:1600600-1605000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr20:1600800-1606200	Enhancers	Primary monocytes fromperipheralblood	blood
23	chr20:1601000-1601600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
24	chr20:1601000-1602200	Enhancers	Primary hematopoietic stem cells	blood
25	chr20:1601000-1603000	Enhancers	Primary T helper cells PMA-I stimulated	--
26	chr20:1601000-1603200	Weak transcription	Hela-S3	cervix
27	chr20:1601200-1601400	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
28	chr20:1601200-1602400	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
29	chr20:1601200-1603200	Weak transcription	Fetal Thymus	thymus
30	chr20:1601200-1604400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
31	chr20:1601200-1604600	Enhancers	Primary T cells from cord blood	blood
32	chr20:1601200-1606200	Enhancers	GM12878-XiMat	blood
33	chr20:1601200-1606600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
34	chr20:1601400-1602400	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
35	chr20:1601400-1604800	Enhancers	Primary hematopoietic stem cells short term culture	blood
36	chr20:1601400-1605200	Weak transcription	HMEC	breast
37	chr20:1601600-1601800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
38	chr20:1601600-1601800	Enhancers	Small Intestine	intestine
39	chr20:1601600-1604000	Weak transcription	Duodenum Smooth Muscle	Duodenum
40	chr20:1601600-1605400	Enhancers	Primary B cells from cord blood	blood
41	chr20:1601800-1602400	Weak transcription	Primary T cells fromperipheralblood	blood
42	chr20:1601800-1602600	Weak transcription	Spleen	Spleen
43	chr20:1601800-1603200	Enhancers	Primary neutrophils fromperipheralblood	blood
44	chr20:1602000-1602400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
45	chr20:1602000-1602600	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
46	chr20:1602200-1603400	Weak transcription	Primary hematopoietic stem cells	blood
47	chr20:1602200-1606000	Enhancers	HUVEC	blood vessel
48	chr20:1602400-1602800	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
49	chr20:1602400-1603200	Enhancers	Monocytes-CD14+_RO01746	blood
50	chr20:1602400-1604000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links